Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)
Study sponsor: VistaGen Therapeutics, Inc. · VTGN
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-09-23Actual
Enrollment · participants481Actual
Source updated2025-10-21Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.